[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368282-105":59,"doc-detail-368282-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","plasma-mir-145-5p-levels-and-risk-of-future-cancer-results-from-the-hunt-study","Plasma miR-145-5p Levels and Risk of Future Cancer - Results from the HUNT Study","","MicroRNA-145-5p (miR-145) regulates multiple oncogenes and is widely considered a tumor suppressor, but whether circulating plasma miR-145 can function as a risk biomarker for future cancer remains unclear. A population-based HUNT cohort (n = 1740) examined associations with first lifetime cancer, cancer stage at diagnosis, and 2-year all-cause mortality after cancer. Cox regression estimated hazard ratios and confidence intervals, showing higher miR-145 levels predicted greater overall cancer incidence.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/plasma-mir-145-5p-levels-and-risk-of-future-cancer-results-from-the-hunt-study/368282/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/plasma-mir-145-5p-levels-and-risk-of-future-cancer-results-from-the-hunt-study/368282.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What question does the study address about miR-145?","Question",{"text":113,"@type":114},"Whether plasma microRNA-145-5p levels can predict risk of future cancer, including cancer stage and short-term survival after diagnosis.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was cancer risk assessed in this research?",{"text":118,"@type":114},"A population-based cohort from the HUNT study was analyzed using Cox regression to estimate hazard ratios and 95% confidence intervals.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the results show about individuals with high plasma miR-145?",{"text":122,"@type":114},"Participants in the highest quartile of plasma miR-145 had a higher risk of developing cancer than those in the lowest quartile, while no clear association was observed for metastatic diagnosis or 2-year mortality.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},368282,1790414542,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nPlasma miR-145-5p Levels and Risk of Future Cancer—Results from the HUNT Study  \nChristopher Antoun 1, *, Julia Oto 2, Vânia M. Morelli 1,3, Kristian Hveem 4,5, Sigrid K. Brækkan 1,3, Pilar Medina 2 and John-Bjarne Hansen 1,3  \nAcademic Editor: Jie Liu  \nReceived: 12 February 2025  \nRevised: 25 February 2025  \nAccepted: 27 February 2025  \nPublished: 28 February 2025  \nCitation: Antoun, C.; Oto, J.; Morelli, V.M.; Hveem, K.; Brækkan, S.K.; Medina, P.; Hansen, J.-B. Plasma miR-145-5p Levels and Risk of Future Cancer—Results from the HUNT Study. Int. J. Mol. Sci. 2025, 26, 2191 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms26052191  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Thrombosis Research Group (TREC), Department of Clinical Medicine, UiT—The Arctic University of Norway, 9019 Tromsø, Norway; [vania.m.morelli@uit.no](vania.m.morelli@uit.no) (V.M.M.); [sigrid.brakkan@uit.no](sigrid.brakkan@uit.no) (S.K.B.); [john-bjarne.hansen@uit.no](john-bjarne.hansen@uit.no) (J.-B.H.)  \n2 Haemostasis, Thrombosis, Arteriosclerosis and Vascular Biology Research Group, Health Research Institute Hospital La Fe, 46026 Valencia, Spain; [julia_oto@iislafe.es](julia_oto@iislafe.es) (J.O.); [medina_pil@gva.es](medina_pil@gva.es) (P.M.)  \n3 Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of North Norway, 9019 Tromsø, Norway  \n4 HUNT Center for Molecular and Clinical Epidemiology, Norwegian University of Science and Technology, 7491 Trondheim, Norway; [kristian.hveem@ntnu.no](kristian.hveem@ntnu.no)  \n5 HUNT Research Center, Department of Public Health and Nursing, Norwegian University of Science and Technology, 7600 Levanger, Norway  \n* Correspondence: [christopher.antoun@uit.no](christopher.antoun@uit.no)  \nAbstract: MicroRNA-145-5p (miR-145) has been reported to regulate multiple oncogenesand is considered a tumor suppressor. However, it remains unknown whether the level of plasma miR-145 can serve as a risk biomarker for future cancer. Using a population-based cohort (n = 1740) derived from the Trøndelag Health Study (HUNT), we investigated whether plasma miR-145 levels were associated with (1) first life-time cancer,(2) cancer stage at diagnosis, and (3) 2-year all-cause mortality after cancer diagnosis. Cox regression analysis was used to estimate hazard ratios (HR) and 95% confidence intervals (CI) . Our findings showed that individuals in the highest quartile of plasma miR-145 levels had a 44% increased risk of developing cancer compared to those in the lowest quartile, independent of age, sex, body mass index, or smoking status (HR 1.44, 95% CI 1.03–2.00 p \u003C 0.05) . However, no association was observed between quartiles of miR-145 levels and the risk of being diagnosed with a metastatic cancer, or the risk of 2-year mortality after cancer diagnosis. Our findings suggest that high plasma miR-145 levels are associated with increased cancer risk without affecting the severity of the cancer at diagnosis or affecting the short-term prognosis.  \nKeywords: microRNAs; cancer; follow-up studies; biomarkers; cohort studies; proportional hazards models  \n1. Introduction  \nEstimates from the GLOBOCAN study in 2022 indicated that around one in nine men and one in twelve women died from cancer [1] . Timely diagnosis can improve these figures [2], but screening efforts for early detection bring their own set of challenges [3,4] . Hence, identifying novel and minimally invasive biomarkers that improve cancer risk stratification might minimize the personal distress and socioeconomic burden of cancer and cancer management in society.  \nDespite its heterogenous nature, a phenomen","cbCaio66xdFlbVBG","https://ap.wps.com/l/cbCaio66xdFlbVBG","pdf",2352259,14,"English","# Abstract\n# Introduction","[{\"question\":\"What question does the study address about miR-145?\",\"answer\":\"Whether plasma microRNA-145-5p levels can predict risk of future cancer, including cancer stage and short-term survival after diagnosis.\"},{\"question\":\"How was cancer risk assessed in this research?\",\"answer\":\"A population-based cohort from the HUNT study was analyzed using Cox regression to estimate hazard ratios and 95% confidence intervals.\"},{\"question\":\"What did the results show about individuals with high plasma miR-145?\",\"answer\":\"Participants in the highest quartile of plasma miR-145 had a higher risk of developing cancer than those in the lowest quartile, while no clear association was observed for metastatic diagnosis or 2-year mortality.\"}]","Plasma miR-145-5p Levels and Risk of Future Cancer - Results from the HUNT Study | PDF",1790176018,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a51e4d83ebe6afef62d8bcdf517f4e01.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa07534e46e87022093e5f7a6e548e66.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0682bd5a935018599d2da8f26b245f80.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8af0ae53d561f3ffbbdae2eedd0a5b06.webp",980,1385]